Table 2. Retinal Disease and Treatment Response Characteristics.
Sample ID | Diagnosis | Vascularization Category | Vitreous Sample Collection Class | Antiangiogenesis Treatment Response |
---|---|---|---|---|
1 | Wet AMD | Neovascularization | Nonresponder | |
3a | Idiopathic CNV | Neovascularization | Pretreatment | NA |
3b | Idiopathic CNV | Neovascularization | Posttreatment | Responder |
4 | Wet AMD | Neovascularization | Nonresponder | |
5 | Wet AMD | Neovascularization | Responder | |
8 | Wet AMD | Neovascularization | Responder | |
9 | Wet AMD | Neovascularization | Responder | |
10a | Wet AMD | Neovascularization | Pretreatment | NA |
10b | Wet AMD | Neovascularization | Posttreatment | Nonresponder |
11 | Wet AMD | Neovascularization | Responder | |
12 | Wet AMD | Neovascularization | Nonresponder | |
13 | Wet AMD | Neovascularization | Nonresponder | |
14 | Wet AMD | Neovascularization | Nonresponder | |
16 | Epiretinal membrane | Nonneovascularization | Control | |
18 | MH | Nonneovascularization | Control | |
21 | Retinal detachment/vitreous membrane | Nonneovascularization | Control | |
22 | Retinal detachment (1 defect) | Nonneovascularization | Control | |
23 | Retinal detachment | Nonneovascularization | Control |
Abbreviations: AMD, age-related macular degeneration; CNV, choroidal neovascularization; MH, macular hole; NA, not applicable.